AAP
TDOC icon

Aristotle Atlantic Partners’s Teladoc Health TDOC Stock Holding History

Aristotle Atlantic Partners’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,000
Closed -$254K – 103
2021
Q3 		$254K Hold
2,000
– – 0.02% 96
2021
Q2 		$333K Hold
2,000
– – 0.02% 97
2021
Q1 		$364K Hold
2,000
– – 0.03% 88
2020
Q4 		$400K Hold
2,000
– – 0.03% 86
2020
Q3 		$438K Hold
2,000
– – 0.04% 82
2020
Q2 		$382K Hold
2,000
– – 0.04% 85
2020
Q1 		$310K Buy
+2,000
New +$233K 0.05% 84

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Aristotle Atlantic Partners's TDOC Position: Q4 2021 in Review

Aristotle Atlantic Partners sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 2,000 shares — an estimated $254K sold.

Aristotle Atlantic Partners first reported a position in TDOC in Q1 2020 and held it in 7 quarters. The position peaked at $438K in Q3 2020. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Aristotle Atlantic Partners reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • Aristotle Atlantic Partners sold 2,000 Teladoc Health shares in Q4 2021, an estimated $254K.
  • Aristotle Atlantic Partners first reported a position in Teladoc Health in Q1 2020 and held it in 7 quarters.
  • Aristotle Atlantic Partners's Teladoc Health position peaked at $438K in Q3 2020.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Aristotle Atlantic Partners's 13F filing for Q4 2021, filed 14 Feb 2022.